Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery

Int J Dermatol. 2000 Jul;39(7):535-8. doi: 10.1046/j.1365-4362.2000.00986-4.x.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Anti-Inflammatory Agents / therapeutic use*
  • Chemistry, Pharmaceutical
  • Clobetasol / analogs & derivatives*
  • Clobetasol / therapeutic use
  • Double-Blind Method
  • Drug Delivery Systems
  • Female
  • Glucocorticoids
  • Humans
  • Male
  • Pharmaceutical Vehicles
  • Psoriasis / drug therapy*
  • Scalp Dermatoses / drug therapy*
  • Solutions
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Pharmaceutical Vehicles
  • Solutions
  • Clobetasol